06May/13

New antiviral treatment could significantly reduce global burden of hepatitis C – University of Bristol

New antiviral treatment could significantly reduce global burden of hepatitis C
University of Bristol
Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer.1 New prevention strategies are urgently required as

and more »